Clinical Trials Directory

Trials / Sponsors / MBX Biosciences

MBX Biosciences

Industry · 7 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Part
Obesity
Phase 12025-09-03
RecruitingStudy to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
Postbariatric Hypoglycemia
Phase 22025-08-26
Active Not RecruitingExtension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroid
Hypoparathyroidism
Phase 22024-10-31
CompletedSafety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism
Hypoparathyroidism
Phase 22024-08-08
CompletedSafety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function
Renal Impairment
Phase 12024-06-13
CompletedSafety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects
Postbariatric Hypoglycemia
Phase 12023-09-18
CompletedSafety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects
Healthy
Phase 12021-11-10